AREV Builds an Industry-Leading Cannabis Topicals Portfolio
Ryan Allway
November 29th, 2018
Exclusive, News, Top Story
The global skincare and dermatology market is projected to grow from $20 billion in 2015 to $33.7 billion by 2022, according to GBI Research, representing a 7.73 percent compound annual growth rate. While premium biologics have become a popular treatment category, the legalization of cannabis has opened the door to the benefits of cannabinoids and terpenes in treating skin-related conditions with topical creams and ointments.
AREV Brands International Inc. (CSE: AREV) has already built a massive product portfolio, targeting everything from cannabis genetics to cultivation to innovative health and wellness products, but skincare represents one of the largest opportunities. Investors may want to take a closer look at the stock after it completed its acquisition of a leading cannabis-infused topicals brand and witnessed early success in its medically-focused studies.
Bare Topicals Adds Leading Brand
AREV Brands recently acquired Bare Topicals from Alternative Extracts Inc. in a stock transaction valued at $160,000. The award-winning cannabis-infused topical products brand aims to relieve pain and treat skin conditions without the side-effects associated with traditional over-the-counter and dermatological products. The brand has been awarded numerous Cannabis Cups in competitions held from Toronto to Vancouver Island, including a second place finish at the 2017 High Times Cannabis Cup Canada.
“This acquisition is another that adds to the portfolio of products AREV continues to assemble while working on obtaining ACMPR licensing to sell any of our cannabis based products,” said CEO Mike Withrow in the press release announcing the acquisition. “In the meantime, we are preparing the Bare Topicals herbal line for production.”
1) Bliss: a cannabis infused lubricant containing cannabis (indica) flower, fractionated coconut oil, sunflower oil, damiana leaf, and ashwagandha2) Heat: a pain reliever and anti-inflammatory with ingredients such as cayenne, ginger, and black pepper to bring heat and increase circulation to arthritic joints.3) Lifted THC infused lip balm: each balm contains 50mg of THC and is flavoured with cucumber melon, and fortified with collagen and additional vitamins A, C, and E.
4) Magik: Pain-relieving, anti-inflammatory, anti-bacterial, anti-rheumatic, astringent and powerful in aiding muscle soreness, arthritis, headaches, cuts and abrasions containing cannabis flower, olive oil, avocado oil, and grapeseed oil.
5) Protect: a restorative hand and body lotion that combines cannabis, calendula, and yarrow, with sunflower and MCT oil.
6) Recover: this highly effective cream combines cannabis (THC) with magnesium and other herbs to effectively relieve pain and promote healing.
7) Releaf pain relief spray: a liniment-type formula which utilizes alcohol extracted THC, beneficial for sore and inflamed joints, circulation problems, and sprains, strains, and bruises.
8) Release: a fast absorbing massage oil, blended with THC and other botanicals designed to relax, reduce pain, and decrease inflammation.
9) Soothe: a rich cannabis cream combined with a multitude of plants to address problematic skin conditions such as eczema, psoriasis, and dermatitis.
Early Success in Medical Studies
AREV Brands recently announced a milestone in one of its joint venture developments with Alternative Extracts Inc. The companies successfully formulated terpenes from non-regulated sources to create a topical product designed to treat burns and insect bites. As noted in peer-reviewed literature, terpene synthesis is vital for cannabinoid synthesis as it provides the GPP molecule for CBGA synthesis.
The formulations have shown early success when applied to burn victims. For example, the company recently cited a 50-year-old woman with a known history of keloid formation. Blisters from the burn she incurred were completely eliminated within four days from the first application without any infection. The mechanism of action is believed to be the result of the poly-molecular function of the terpenes.
“This collaboration continues to produce highly effective compounds and formulations,” said Dr. Adrian Wade, Chief Science Officer, of Alternative Extracts Inc. in the press release announcing the early-stage results. “Terpenes have demonstrated to play an important role in an increasing number of natural health and medical products.”
Looking Ahead
AREV Brands International Inc. (CSE: AREV) has been making significant progress in advancing its product development an ACMPR license application over the past several months. With its renewed focus on skincare and dermatology, investors may want to take a closer look at the stock over the coming months as it rolls out new products.
For more information, visit the company’s website at www.arevbrands.com.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The company’s leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a […]
Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America. It is leveraging its 30-years as a mega-scale, low-cost greenhouse grower to capitalize on the cannabis opportunity in Canada.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
